Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

BORA study investigators

Research output: Contribution to journal › Article › peer-review

230 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial'. Together they form a unique fingerprint.

Medicine & Life Sciences